SCHEMBL44837

SCHEMBL44837

OCc1ccccc1C(F)(F)F

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.57
POLQ O75417 1/20 0.47
ALDH1A1 P00352 2/20 0.47
KDM4E B2RXH2 1/20 0.47
ATM Q13315 1/20 0.47
POLB P06746 2/20 0.45
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
MAOB P27338 3/20 0.45
AR P10275 1/20 0.45
MAOA P21397 1/20 0.45
APOBEC3G Q9HC16 1/20 0.44
KMT2A Q03164 1/20 0.44
GRIN1 Q05586 1/20 0.44
GRIN2B Q13224 1/20 0.44
HDAC1 Q13547 1/20 0.42
HDAC8 Q9BY41 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29389277 1.00 IDO1 (0.57) IDO1POLQALDH1A1KDM4EATM
Phthalic Acid SCHEMBL3628700 0.84 ALDH1A1 (0.50) IDO1POLQALDH1A1KDM4EATM
SCHEMBL979275 0.84 IDO1 (0.52) IDO1POLQALDH1A1KDM4EATM
SCHEMBL30019530 0.84 IDO1 (0.52) IDO1POLQALDH1A1KDM4EATM
SCHEMBL2968062 0.83 IDO1 (0.55) IDO1POLQALDH1A1KDM4EATM
SCHEMBL542693 0.82 IDO1 (0.41) IDO1POLQALDH1A1KDM4EATM
SCHEMBL1607338 0.82 AKR1B1 (0.42) IDO1
SCHEMBL30368290 0.82 IDO1 (0.41) IDO1POLQALDH1A1KDM4EATM
SCHEMBL17329111 0.82 IDO1 (0.59) IDO1POLQALDH1A1KDM4EATM
SCHEMBL3647884 0.82 IDO1 (0.59) IDO1POLQALDH1A1KDM4EATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 647 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118384915-A High-efficiency furfural oxidation active electrocatalyst based on electron beam irradiation and preparation method and application thereof 上海大学 2024-07-26 CN claimed
CN-116440926-B Modified ZnIn2S4/BiVO4Heterojunction between benzyl alcohol and CO2Application in photocatalytic carboxylation 重庆工商大学 2024-07-02 CN claimed
CN-117867555-A Fluorine-doped carbon quantum dot catalyst for reducing methane by high-efficiency electrocatalytic carbon dioxide, and preparation method and application thereof 上海大学 2024-04-12 CN claimed
CN-116440926-A Modified ZnIn 2 S 4 /BiVO 4 Heterojunction between benzyl alcohol and CO 2 Application in photocatalytic carboxylation 重庆工商大学 2023-07-18 CN claimed
CN-110407677-B Preparation method and application of diphenylethanedione compound 南京先进生物材料与过程装备研究院有限公司 2022-10-11 CN claimed
US-20220033634-A1 CURABLE FLUORINE-BASED ELASTOMER COMPOSITE AND CURED PRODUCT THEREOF 3M INNOVATIVE PROPERTIES COMPANY 2022-02-03 US claimed
EP-3856830-A1 CURABLE FLUORINE-BASED ELASTOMER COMPOSITE AND CURED PRODUCT THEREOF 3M Innovative Properties Company (US) 2021-08-04 EP claimed
WO-2020065467-A1 CURABLE FLUORINE-BASED ELASTOMER COMPOSITE AND CURED PRODUCT THEREOF 3M INNOVATIVE PROPERTIES COMPANY (US) 2020-04-02 WO claimed
CN-110407677-A The preparation method and application of benzil class compound NANJING ADVANCED BIOMATERIALS AND PROCESS EQUIPMENT RES INSTITUTE CO LTD 2019-11-05 CN claimed
CN-109810572-A Inorganic nano material prints ink and its preparation method and application 深圳TCL工业研究院有限公司 2019-05-28 CN claimed
EP-2206002-A1 DIFFRACTIVE OPTICAL ELEMENT AND USE OF AN OPTICAL ADHESIVE FOR PRODUCING THE SAME Carl Zeiss AG (DE) 2010-07-14 EP claimed
WO-2009056196-A1 DIFFRACTIVE OPTICAL ELEMENT AND USE OF AN OPTICAL ADHESIVE FOR PRODUCING THE SAME CARL ZEISS AG (DE) 2009-05-07 WO claimed
EP-2019817-A2 PROCESSES FOR THE PREPARATION OF R-(+)-3-(CARBAMOYL METHYL)-5-METHYLHEXANOIC ACID AND SALTS THEREOF TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2009-02-04 EP claimed
US-7462738-B2 Processes for the preparation of R-(+)-3-(carbamoyl methyl)-5-methylhexanoic acid and salts thereof TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2008-12-09 US claimed
US-20070293694-A1 Processes for the preparation of R-(+)-3-(carbamoyl methyl)-5-methylhexanoic acid and salts thereof TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) 2007-12-20 US claimed
WO-2007139933-A2 PROCESSES FOR THE PREPARATION OF R-(+)-3-(CARBAMOYL METHYL)-5-METHYLHEXANOIC ACID AND SALTS THEREOF TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2007-12-06 WO claimed
US-6989052-B1 Phase change ink printing process XEROX CORPORATION (US) 2006-01-24 US claimed
US-20060004123-A1 PHASE CHANGE INK PRINTING PROCESS XEROX CORPORATION 2006-01-05 US claimed
CN-1226258-C Process for producing fluorinated methyl-benzyl alcohol SHOWAN DENKO K K (JP) 2005-11-09 CN claimed
CN-1466560-A Process for producing fluorinated methyl-benzyl alcohol �Ѻ͵繤��ʽ���� 2004-01-07 CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293694-A1 Processes for the preparation of R-(+)-3-(carbamoyl methyl)-5-methylhexanoic acid and salts thereof RIMKLA, GABRE, GRIK5 IDO1 3753/4885POLQ 4361/4885ALDH1A1 1872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.